ZoomInfo Priced 20M Share Offering Via TA Associates, The Carlyle Group, 22C Capital At $63/Share

ZoomInfo Technologies Inc. ("ZoomInfo") ZI today announced the pricing of the previously announced secondary offering by certain selling stockholders of ZoomInfo, including investment funds affiliated

ZoomInfo Technologies Inc. ("ZoomInfo") ZI today announced the pricing of the previously announced secondary offering by certain selling stockholders of ZoomInfo, including investment funds affiliated with TA Associates ("TA"), The Carlyle Group ("Carlyle") and 22C Capital LLC ("22C Capital") and an entity affiliated with ZoomInfo's co-founders (together with TA, Carlyle and 22C Capital, the "Selling Stockholders"), of 20,000,000 shares of ZoomInfo's Class A common stock pursuant to ZoomInfo's shelf registration statement filed with the Securities and Exchange Commission (the "SEC") at the public offering price of $63.00 per share. Additionally, the Selling Stockholders granted the underwriter a 30-day option to purchase up to an additional 3,000,000 shares of ZoomInfo's Class A common stock. The Selling Stockholders will receive all of the proceeds from this offering. No shares are being sold by ZoomInfo. The last reported sale price of ZoomInfo's Class A common stock on August 6, 2021 was $64.54 per share. The offering is expected to close on August 11, 2021, subject to customary closing conditions.

Morgan Stanley is acting as the underwriter for the offering.

A registration statement relating to these securities has been filed with the SEC and has become effective. This news release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering of these securities will be made only by means of a prospectus. Copies of the prospectus and any prospectus supplement, when available, may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014.